# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Squamous cell carcinoma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 686 results.
Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma
Status: Recruiting
Last Changed: Jun 14, 2019
First Received: Sep 11, 2017
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): Nivolimumab+Carboplatin/paclitaxel+Radiation
Locations: University of Califonia, San Diego, La Jolla, California, United States
University of Southern California, Los Angeles, California, United States
New York University School of Medicine, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Oregon Health Sciences University, Portland, Oregon, United States
... and 1 other locations.
A Study of Triprizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
Status: Recruiting
Last Changed: Sep 10, 2019
First Received: Sep 10, 2019
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): Triprizumab, Paclitaxel, Albumin-Bound, Radiotherapy, Platinum-Based Drug
Locations: Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
PET-CT Guided Optimal Radiotherapy Dose for II/III Esophageal Squamous Cell Carcinoma
Status: Recruiting
Last Changed: Jan 02, 2020
First Received: Dec 27, 2019
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): PET-CT
Locations: Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma
Status: Recruiting
Last Changed: Dec 17, 2019
First Received: Sep 06, 2018
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): Moderately hypofractionated conformal radiation combined With S-1
Locations: Hui Liu, Guangzhou, Guangdong, China
Toripalimab With Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Status: Not yet recruiting
Last Changed: Jan 09, 2020
First Received: Nov 26, 2019
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): Toripalimab
Locations: Sichuan Cancer Hospital and Research Institute, Chengdu, Sichuan, China
Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.
Status: Recruiting
Last Changed: Jan 18, 2020
First Received: Jan 18, 2020
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): Cisplatin, 5-FU, Radiation therapy, Cetuximab, Nivolumab
Locations: Rabin Medical Center, Petach Tikva, Israel
Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo)
Status: Not yet recruiting
Last Changed: Feb 15, 2019
First Received: Feb 07, 2019
Disease(s): Esophageal Squamous Cell Carcinoma
Intervention(s): metformin and chemotherapy
Locations: Peking Universtiy Cancer Hospital, Beijing, Beijing, China
Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging
Status: Recruiting
Last Changed: Jan 10, 2020
First Received: Jan 10, 2020
Disease(s): Oropharyngeal Squamous Cell Carcinoma
Intervention(s): RGD PET/CT
Locations: Radboudumc, Nijmegen, Gelderland, Netherlands
Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma
Status: Recruiting
Last Changed: Mar 14, 2019
First Received: Oct 25, 2018
Disease(s): Squamous Cell Carcinoma
Intervention(s): Onivyde, Paclitaxel
Locations: Ch Perpignan, Perpignan, France
Chu de Poitiers, Poitiers, France
Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
Status: Recruiting
Last Changed: Apr 19, 2019
First Received: Feb 10, 2016
Disease(s): Head and Neck Squamous Cell Carcinoma
Intervention(s): 18-F FDG
Locations: University Health Network, Princess Margaret Cancer Center, Toronto, Ontario, Canada